IDiyas

For the Inventor, By the Inventor

Seeshaupt, Germany

Peter Roeschlau

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 533(Granted Patents)


Location History:

  • Tutzing, Upper Bavaria, DE (1976)
  • Tutzing, DE (1979 - 1980)
  • Seeshaupt, DE (1978 - 1987)

Company Filing History:

goldMedal12 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1976-1987

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4716119 - Control serum and process therefor (1987-12-29),
2. 4692406 - Process and a reagent for the simultaneous determination of fibrinogen (1987-09-08),
3. 4458015 - Reagent for the optical determination of the blood coagulation (1984-07-03),
4. 4429040 - Method and reagent for the detection of fibrin monomer (1984-01-31),
5. 4409327 - Process and reagent for the determination of the biological activity of (1983-10-11),
6. 4212938 - Reagent and method for the determination of cholesterol (1980-07-15),
7. 4184921 - Process and reagent for determining cholesterol (1980-01-22),
8. 4181575 - Composition and method for the determination of cholesterol (1980-01-01),
9. 4168205 - Method for the determination of substrates or enzyme activities (1979-09-18),
10. 4164448 - Activation of cholesterol oxidase for cholesterol assay (1979-08-14),
11. 4123384 - Control serum containing alkaline phosphatase of constant activity (1978-10-31),
12. 3948728 - Steroid-delta-isomerase (1976-04-06),

Title: Innovations of Peter Roeschlau

Introduction

Peter Roeschlau is a notable inventor based in Seeshaupt, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of innovative processes and reagents for medical applications. With a total of 12 patents to his name, Roeschlau's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents is the invention of a control serum and the associated process. This control serum contains at least one compound of a specific formula, which plays a crucial role in various biochemical applications. Another significant patent involves a process for the simultaneous determination of fibrinogen and fibrinogen fission products in plasma. This process utilizes a snake venom enzyme with thrombin-like effectiveness, allowing for precise measurements of fibrinogen levels in plasma samples.

Career Highlights

Peter Roeschlau is currently associated with Boehringer Mannheim GmbH, a company known for its advancements in medical technology and diagnostics. His work at the company has been instrumental in developing innovative solutions that enhance the accuracy and efficiency of medical testing.

Collaborations

Throughout his career, Roeschlau has collaborated with esteemed colleagues such as Gunter Lang and Wolfgang Gruber. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of scientific knowledge.

Conclusion

Peter Roeschlau's contributions to the field of biochemistry through his patents and collaborations highlight his role as a leading inventor. His innovative work continues to influence medical diagnostics and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…